» Articles » PMID: 9277131

Endocytosis and Recycling of G Protein-coupled Receptors

Overview
Specialty Pharmacology
Date 1997 Aug 1
PMID 9277131
Citations 67
Authors
Affiliations
Soon will be listed here.
Abstract

Agonist stimulation of G protein-coupled receptors causes a dramatic reorganization of their intracellular distribution. Activation of receptors triggers receptor endocytosis and, since receptors recycle back to the surface continuously, a new steady state is reached where a significant proportion of receptors is located internally. Although this movement of receptors is remarkable, its role has been enigmatic. Recent developments have provided insight into the compartments through which the receptors move, the nature of the signals that trigger receptor translocation, and the significance of receptor cycling for cell function. In this article, Jennifer Koenig and Michael Edwardson review recent progress in this field and place receptor cycling into a mathematical framework that reveals the extent and rate of intracellular receptor movement.

Citing Articles

Orphan G protein-coupled receptors: the ongoing search for a home.

Jobe A, Vijayan R Front Pharmacol. 2024; 15:1349097.

PMID: 38495099 PMC: 10941346. DOI: 10.3389/fphar.2024.1349097.


Patterns of human and porcine gammaherpesvirus-encoded BILF1 receptor endocytosis.

Mavri M, Glisic S, Sencanski M, Vrecl M, Rosenkilde M, Spiess K Cell Mol Biol Lett. 2023; 28(1):14.

PMID: 36810008 PMC: 9942385. DOI: 10.1186/s11658-023-00427-y.


Extracellular Matrix Recycling as a Novel Plasticity Mechanism With a Potential Role in Disease.

Dankovich T, Rizzoli S Front Cell Neurosci. 2022; 16:854897.

PMID: 35431813 PMC: 9008140. DOI: 10.3389/fncel.2022.854897.


The Synaptic Extracellular Matrix: Long-Lived, Stable, and Still Remarkably Dynamic.

Dankovich T, Rizzoli S Front Synaptic Neurosci. 2022; 14:854956.

PMID: 35350469 PMC: 8957932. DOI: 10.3389/fnsyn.2022.854956.


Distinct In Vitro Binding Profile of the Somatostatin Receptor Subtype 2 Antagonist [Lu]Lu-OPS201 Compared to the Agonist [Lu]Lu-DOTA-TATE.

Mansi R, Plas P, Vauquelin G, Fani M Pharmaceuticals (Basel). 2021; 14(12).

PMID: 34959665 PMC: 8706879. DOI: 10.3390/ph14121265.